Omnicell (OMCL) | Stock Overview & Key Data
Omnicell Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $187.29 on November 22, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Omnicell
OMCL
|
1.65B Small-cap | -4.67% | -7.26% | 16.62% | -7.58% | -11.41% | 29.33% | -47.23% | -73.67% | 16.01% | 151.70% | 181.05% |
|
Ge Healthcare
GEHC
|
31.89B Large-cap | 0.14% | 6.58% | -10.27% | -23.32% | -21.81% | -9.79% | -17.13% | 14.87% | 14.87% | 14.87% | 14.87% |
|
Veeva Systems
VEEV
|
26.49B Large-cap | -3.03% | 2.08% | -12.47% | -26.32% | -26.12% | -43.54% | -20.25% | -47.98% | 374.26% | 259.41% | 259.41% |
|
Teladoc Health
TDOC
|
1.04B Small-cap | 5.37% | 17.30% | 38.40% | 1.63% | 5.82% | 7.00% | -70.52% | -95.30% | -42.92% | -73.79% | -73.79% |
|
Certara
CERT
|
969.01M Small-cap | -0.19% | 16.29% | -19.72% | -40.39% | -40.39% | -52.77% | -70.03% | -81.17% | -86.34% | -86.34% | -86.34% |
|
Schrodinger
SDGR
|
870.40M Small-cap | 1.39% | 22.18% | 14.96% | -19.82% | -18.80% | -32.57% | -68.57% | -80.48% | -54.73% | -54.73% | -54.73% |
Ownership & Short Interest
Calculate Your Omnicell Investment Returns
Long-Term Investment Performance Analysis
Omnicell stock price in Jul 2016 was $35.37, A $1,000.00 lump sum investment in Omnicell made 9 years ago would be worth approximately $1,130.62 today, representing a positive return of 13.06%. This translates to an annualized return (CAGR) of 1.25%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is OMCL's 52-week high and low?
- In the last 52 weeks, Omnicell reached a high of $55.00 (on January 13, 2026) and a low of $26.85 (on July 18, 2025).
- What is the market cap and P/E ratio for OMCL?
- Curious about Omnicell's size and valuation? Its market capitalization stands at 1.65B. When it comes to valuation, the P/E ratio (trailing twelve months) is 918.75, and the forward P/E (looking ahead) is 17.60.
- Does OMCL pay dividends? If so, what's the yield?
- As for dividends, Omnicell isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Omnicell's main competitors or similar companies to consider before investing?
When looking at Omnicell, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Ge Healthcare
GEHC31.89B Healthcare Health Information Services -9.79% -17.13% Veeva Systems
VEEV26.49B Healthcare Health Information Services -43.54% -20.25% Teladoc Health
TDOC1.04B Healthcare Health Information Services 7.00% -70.52% Certara
CERT969.01M Healthcare Health Information Services -52.77% -70.03% Schrodinger
SDGR870.40M Healthcare Health Information Services -32.57% -68.57% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Omnicell Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Omnicell's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.17%, the Debt to Equity ratio from the most recent quarter is 16.59, and its Gross Profit Margin stands at 41.51%.
- What is the recent revenue and earnings growth for OMCL?
- Looking at Omnicell's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.30%, and quarterly earnings saw a YoY growth of N/A.
- How much of OMCL stock is held by insiders and institutions?
- Wondering who owns Omnicell stock? Company insiders (like executives and directors) hold about 2.20% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 106.39%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.